GSS 3.50% 69.0¢ genetic signatures limited

Ann: CE-IVD received for COVID-19 test, page-22

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 734 Posts.
    lightbulb Created with Sketch. 73
    Still more good news to come. Tga approval pending - probably get it by tmr or on Friday - start selling to healthscope and ramp up testing. FDA approval also on the horizon. GSS's test kit on par or even better than Roche's cobas, Abbott's m2000, seegens allplex.
    New contract with European pathology providers on the horizon as well. Covid-19 might slow down worldwide In the next coming months but testing should keep their numbers. At least labs will switch from kit specific to sars-cov-2 to respiratory tract viruses pan - panel test kits that includes sars-cov-2 as one of the targets.

 
watchlist Created with Sketch. Add GSS (ASX) to my watchlist
(20min delay)
Last
69.0¢
Change
-0.025(3.50%)
Mkt cap ! $156.5M
Open High Low Value Volume
68.5¢ 69.0¢ 68.5¢ $13.72K 20.03K

Buyers (Bids)

No. Vol. Price($)
1 8524 69.0¢
 

Sellers (Offers)

Price($) Vol. No.
71.5¢ 3598 2
View Market Depth
Last trade - 15.44pm 15/11/2024 (20 minute delay) ?
GSS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.